RA Capital Management - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q1 2021$48,211,000
+4.8%
2,118,2120.0%0.73%
+13.1%
Q4 2020$45,986,000
+116.0%
2,118,2120.0%0.64%
+65.3%
Q3 2020$21,288,000
+42.9%
2,118,212
+10.3%
0.39%
+34.1%
Q2 2020$14,896,0001,919,6440.29%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders